Details of the Drug Reposition

General Information of This Drug (ID: DMKUE8O)

Drug Name
RP5063   DMKUE8O

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Phase 2 [1]
------------------------------------------------------------------------------------
5 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Attention deficit hyperactivity disorder DISL8MX9 6A05.Z Phase 1 [2]
Bipolar disorder DISAM7J2 6A60 Phase 1 [2]
Major depressive disorder DIS4CL3X 6A70.3 Phase 1 [2]
Parkinson disease DISQVHKL 8A00.0 Phase 1 [2]
Alzheimer disease DISF8S70 8A20 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01490086) RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)